New guidance on naloxone to strengthen work of harm reduction groups
The guidance announced today offers regulatory clarity for harm reduction organizations to purchase naloxone so more will be distributed in communities.
Patient Support & Advocacy
AMA advocacy 2022 efforts
The AMA advocates at the federal and state levels on key health care issues impacting patients and physicians. See updates of some of the recent efforts.
Barriers to care cause drug overdose and death epidemic to deepen
Illicit drugs are fueling the overdose epidemic. A new AMA report makes clear how physicians, payers, policymakers and others can help save lives.
Trends on overdose deaths require specific actions, all-hands approach
With a report issued today detailing the horrific toll of the nation’s overdose and death epidemic, the AMA calls for an all-hands approach to help save lives.
Bobby Mukkamala, MD, on tangible actions to reverse the overdose epidemic [Podcast]
The AMA is leading the fight against the COVID-19 pandemic. Listen to podcast updates on how the AMA is fighting COVID-19 by discussing actions to reverse the overdose epidemic.
Bobby Mukkamala, MD, on tangible actions to reverse the overdose epidemic
The AMA is leading the fight against the COVID-19 pandemic. See video updates on how the AMA is fighting COVID-19 by discussing actions to reverse the overdose epidemic.
Accelerating Change in Medical Education
Working with health care delivery systems in novel ways
See how consortium schools are partnering with health care systems to bring students out of classrooms so they can learn in authentic health care settings.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights